Sports / Entertainment

Special Report: Creating a Safer Treatment to Counteract the Effect of Blood Thinners
LOS ANGELES, CA–(Marketwire – 01/14/11) – The search for viable alternatives to protamine is clearly an important one, but to date it has generated few successes. One prominent new player in the quest is PolyMedix, Inc. (OTC.BB: PYMX – News ), based in Radnor, Pennsylvania. The company has developed novel small molecules, which it has dubbed “heptagonists,” that act to reverse the anticoagulant …

Read more on Marketwire via Yahoo! Finance

EDP Biotech receives $244,000 grant under QTDP program for colon cancer blood test
EDP Biotech Corporation was awarded a $244,000 grant from the federal government under the Qualifying Therapeutic Discovery Project program as a result of the company’s work in the development of their ColoMarker test, an early detection blood test for colon cancer.

Read more on News-Medical-Net

University of Florida College of Veterinary Medicine gets Daxor’s blood volume analyzer
Daxor Corporation, a medical instrumentation and biotechnology company has , received a signed trial agreement from The University of Florida College of Veterinary Medicine in Gainesville, Florida which will provide the Veterinary Medical Center with a Blood Volume Analyzer-100 (BVA-100), an instrument which enables semi-automated measurement of a patient’s total blood volume, red blood cell …

Read more on PharmaBiz